GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia.

Abstract

This study aimed to investigate the binding affinity of [3H]GABA and [3H]beta-alanine to GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex (Brodmanns' area 9) in schizophrenia. Using post mortem tissue from individuals diagnosed with schizophrenia (n=6) and control subjects (n=6), the density of GAT-1 was established by displacing [3H]GABA with muscimol, and for GAT-3 [3H]beta-alanine was used. Data analysis showed a significant decrease of GAT-1 levels (45%), and a significant increase of GAT-3 density (23%) within the dorsolateral prefrontal cortex of individuals diagnosed with schizophrenia when compared to age- and sex-matched controls. The observed decrease of GAT-1 could be explained as a consequence of the GABA hypo-function or the result of volumetric shrinkage of the cerebral cortex previously reported in this disease. The observed elevation of GAT-3 levels could be due to a compensatory effect for any functional loss of GABA re-uptake by the decreased GAT-1 levels.

0102030'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

102 Citations

Semantic Scholar estimates that this publication has 102 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Schleimer2004GABATG, title={GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia.}, author={Sonja B Schleimer and Tina Hinton and Gavin Dixon and Graham A. R. Johnston}, journal={Neuropsychobiology}, year={2004}, volume={50 3}, pages={226-30} }